EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Long-term Effect of Helicobacter pylori Eradication on Risk Factors for Cardiovascular Disease – Is there a Connection?

Katja Tepes, Sitke Aygen, Gorazd Avgustin, Rok Orel, David Stubljar, Bojan Tepes

Journal of Gastrointestinal and Liver Diseases · 27.03.2026 · 35 (1) · 23-30

DOI: 10.15403/jgld-6725 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 27.03.2026. Verfasst von Katja Tepes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Diagnostic Center Rogaška, Rogaška Slatina; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. katja.tepe…. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Cardiovascular Diseases, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. Beyond traditional risk factors, chronic inflammation is increasingly recognized in its pathogenesis. Helicobacter pylori (H. pylori) infection has been proposed as a potential contributor. This study aimed to investigate the long-term effects of successful H. pylori eradication on selected CVD risk factors.

Methods

Seventy-two patients were enrolled between July 2020 and November 2022 and randomized to two 14-day regimens (group 1: esomeprazole, amoxicillin, clarithromycin; group 2: esomeprazole, amoxicillin, metronidazole, colloidal bismuth subcitrate). Outcomes included homeostatic model assessment of insulin resistance (HOMA-IR) index, lipid profiles and subfractions, and urinary trimethylamine N-oxide (TMAO), assessed by nuclear magnetic resonance spectroscopy. Assessments were performed at baseline, two months, and one year after confirmed H. pylori eradication.

Results

Of the 72 enrolled patients, 13.9% (10/72) were lost to follow-up. Baseline CVD risk factors did not differ significantly between groups. After successful eradication, both groups demonstrated significant reductions in total cholesterol (p=0.003), low-density lipoprotein cholesterol (p=0.010), small dense lipoprotein particles (p=0.037), and marginal decrease in TMAO concentrations (p=0.048). No significant changes were observed in body mass index (p=0.799), waist circumference (p=0.305), or HOMA-IR index (p=0.275).

Conclusions

Successful eradication of H. pylori infection was associated with favorable changes in lipid metabolism and marginal decrease in TMAO levels. These findings suggest that H. pylori may contribute to CVD risk by modulating lipoprotein profiles and systemic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriCardiovascular DiseasesAnti-Bacterial AgentsHumansFemaleMaleMiddle AgedAmoxicillinHeart Disease Risk FactorsTime FactorsEsomeprazoleDrug Therapy, CombinationClarithromycinRisk FactorsOrganometallic CompoundsInsulin ResistanceProton Pump InhibitorsMetronidazoleAgedTreatment OutcomeMethylamines

Substanzen

Anti-Bacterial AgentsAmoxicillinEsomeprazoleClarithromycinOrganometallic Compoundsbismuth tripotassium dicitrateProton Pump InhibitorsMetronidazoletrimethyloxamineMethylamines

Autor:innen und Institutionen

  • Department of Gastroenterology, Diagnostic Center Rogaška, Rogaška Slatina; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. katja.tepes@gmail.com.
  • INFAI GmbH, Cologne, Germany. sa@infai.de.
  • University of Ljubljana, Biotechnical Faculty, Department of Microbiology, Ljubljana, Slovenia. gorazd.avgustin@bf.uni-lj.si.
  • Department of Gastroenterology, Hepatology and Nutrition, University Medical centre Ljubljana, University Children's Hospital Ljubljana, Ljubljana, Slovenia. rok.orel@kclj.si.
  • Department of Research & Development, In-Medico, Metlika, Slovenia. d.stubljar@gmail.com.
  • Department of Gastroenterology, Diagnostic Center Rogaška, Rogaška Slatina; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. bojan.tepes@siol.net.

Zitieren

APA

Tepes, K., Aygen, S., Avgustin, G., Orel, R., Stubljar, D., & Tepes, B. (2026). Long-term Effect of Helicobacter pylori Eradication on Risk Factors for Cardiovascular Disease – Is there a Connection?. Journal of Gastrointestinal and Liver Diseases, 35(1), 23-30. https://doi.org/10.15403/jgld-6725

Vancouver

Tepes K, Aygen S, Avgustin G, Orel R, Stubljar D, Tepes B. Long-term Effect of Helicobacter pylori Eradication on Risk Factors for Cardiovascular Disease – Is there a Connection?. Journal of Gastrointestinal and Liver Diseases. 2026;35(1):23-30. doi:10.15403/jgld-6725

BibTeX
@article{Tepes2026,
  author = {Tepes, Katja and Aygen, Sitke and Avgustin, Gorazd and Orel, Rok and Stubljar, David and Tepes, Bojan},
  title = {Long-term Effect of Helicobacter pylori Eradication on Risk Factors for Cardiovascular Disease – Is there a Connection?},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2026},
  volume = {35},
  number = {1},
  pages = {23--30},
  doi = {10.15403/jgld-6725}
}
Kostenlos starten →